Nutex Health, Inc. (NUTX)
USD 66.86
(-6.32%)
USD 66.86
(-6.32%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -45.78 Million USD | 89.42% |
| 2022 | -432.73 Million USD | -426.37% |
| 2021 | 132.59 Million USD | 25.12% |
| 2020 | 105.96 Million USD | 542.89% |
| 2019 | 16.48 Million USD | 685.72% |
| 2018 | -2.81 Million USD | -583.5% |
| 2017 | 582.06 Thousand USD | 107.83% |
| 2016 | -7.43 Million USD | -8968.07% |
| 2015 | 83.8 Thousand USD | 0.0% |
| 2011 | -383.39 Thousand USD | -342.44% |
| 2010 | 158.13 Thousand USD | -73.87% |
| 2009 | 605.28 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -364.07 Thousand USD | 98.85% |
| 2024 Q2 | -364.04 Thousand USD | 0.01% |
| 2023 Q4 | -31.61 Million USD | -470.47% |
| 2023 Q1 | -5.14 Million USD | 51.71% |
| 2023 Q2 | -3.47 Million USD | 32.41% |
| 2023 Q3 | -5.54 Million USD | -59.31% |
| 2023 FY | -45.78 Million USD | 89.42% |
| 2022 Q2 | -23.47 Million USD | -41.7% |
| 2022 Q3 | -433.24 Million USD | -1745.29% |
| 2022 FY | -432.73 Million USD | -426.37% |
| 2022 Q1 | -16.56 Million USD | -210.05% |
| 2022 Q4 | -10.65 Million USD | 97.54% |
| 2021 FY | 132.59 Million USD | 25.12% |
| 2021 Q2 | 27.05 Million USD | 708.82% |
| 2021 Q4 | 15.05 Million USD | -72.01% |
| 2021 Q3 | 53.79 Million USD | 98.8% |
| 2021 Q1 | -4.44 Million USD | -111.04% |
| 2020 Q2 | 227.3 Thousand USD | 120.25% |
| 2020 Q4 | 40.25 Million USD | 2192.14% |
| 2020 FY | 105.96 Million USD | 542.89% |
| 2020 Q1 | -1.12 Million USD | 80.0% |
| 2020 Q3 | 1.75 Million USD | 672.59% |
| 2019 Q4 | -5.61 Million USD | -1401.82% |
| 2019 FY | 16.48 Million USD | 685.72% |
| 2019 Q1 | -559.36 Thousand USD | 35.66% |
| 2019 Q3 | -373.74 Thousand USD | 34.47% |
| 2019 Q2 | -570.36 Thousand USD | -1.97% |
| 2018 Q1 | -610.03 Thousand USD | 84.53% |
| 2018 Q4 | -869.44 Thousand USD | -42.88% |
| 2018 FY | -2.81 Million USD | -583.5% |
| 2018 Q3 | -608.51 Thousand USD | 16.21% |
| 2018 Q2 | -726.24 Thousand USD | -19.05% |
| 2017 Q2 | -1.64 Million USD | 0.0% |
| 2017 Q3 | 6.32 Million USD | 483.97% |
| 2017 FY | 582.06 Thousand USD | 107.83% |
| 2017 Q4 | -3.94 Million USD | -162.33% |
| 2016 FY | -7.43 Million USD | -8968.07% |
| 2015 FY | 83.8 Thousand USD | 0.0% |
| 2011 Q4 | -153.2 Thousand USD | 0.17% |
| 2011 Q1 | 45.52 Thousand USD | 112.68% |
| 2011 Q2 | -122.23 Thousand USD | -368.53% |
| 2011 Q3 | -153.47 Thousand USD | -25.56% |
| 2011 FY | -383.39 Thousand USD | -342.44% |
| 2010 FY | 158.13 Thousand USD | -73.87% |
| 2010 Q4 | -359.07 Thousand USD | -329.9% |
| 2010 Q3 | 156.18 Thousand USD | -23.75% |
| 2010 Q1 | 156.18 Thousand USD | 0.0% |
| 2010 Q2 | 204.83 Thousand USD | 31.15% |
| 2009 FY | 605.28 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| CareCloud, Inc. | -48.67 Million USD | 5.932% |
| Augmedix, Inc. | -19.17 Million USD | -138.833% |
| BrightSpring Health Services, Inc. Common Stock | -154.6 Million USD | 70.384% |
| CareCloud, Inc. | -48.67 Million USD | 5.932% |
| HealthEquity, Inc. | 55.71 Million USD | 182.184% |
| iCoreConnect Inc. | -15.55 Million USD | -194.416% |
| Inovalon Holdings, Inc. | 22.57 Million USD | 302.784% |
| Omnicell, Inc. | -20.37 Million USD | -124.764% |
| OneMedNet Corporation | -23.2 Million USD | -97.31% |
| Progyny, Inc. | 62.03 Million USD | 173.805% |
| Renalytix Plc | -33.45 Million USD | -36.856% |
| Schrödinger, Inc. | 40.72 Million USD | 212.443% |
| Simulations Plus, Inc. | 9.95 Million USD | 559.982% |
| SOPHiA GENETICS SA | -78.98 Million USD | 42.028% |
| Streamline Health Solutions, Inc. | -18.69 Million USD | -144.887% |
| Ontrak, Inc. | -27.92 Million USD | -63.992% |
| GE HealthCare Technologies Inc. | 1.56 Billion USD | 102.92% |
| Sharecare, Inc. | -128.49 Million USD | 64.368% |
| Aclarion, Inc. | -4.91 Million USD | -832.257% |
| CareMax, Inc. | -683.34 Million USD | 93.3% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.35 Million USD | -754.887% |
| Forian Inc. | 11.1 Million USD | 512.244% |
| Bullfrog AI Holdings, Inc. Warrants | -5.35 Million USD | -754.887% |
| HeartBeam, Inc. | -14.63 Million USD | -212.771% |
| GeneDx Holdings Corp. | -175.76 Million USD | 73.95% |
| SCWorx Corp. | -3.98 Million USD | -1050.087% |
| Minerva Surgical, Inc. | -34.11 Million USD | -34.224% |
| Definitive Healthcare Corp. | -202.38 Million USD | 77.377% |
| 10x Genomics, Inc. | -255.09 Million USD | 82.051% |
| Zhongchao Inc. | -11.33 Million USD | -303.908% |
| Accolade, Inc. | -99.8 Million USD | 54.124% |
| MSP Recovery, Inc. | -56.34 Million USD | 18.743% |
| R1 RCM Inc. | 3.3 Million USD | 1487.473% |
| Spok Holdings, Inc. | 15.66 Million USD | 392.267% |
| Privia Health Group, Inc. | 23.07 Million USD | 298.391% |
| EUDA Health Holdings Limited | -10.03 Million USD | -356.066% |
| TruBridge, Inc. | -45.78 Million USD | 0.005% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | -154.6 Million USD | 70.384% |
| Sharecare, Inc. | -128.49 Million USD | 64.368% |
| Health Catalyst, Inc. | -118.14 Million USD | 61.246% |
| GoodRx Holdings, Inc. | -8.86 Million USD | -416.313% |
| Premier, Inc. | 119.54 Million USD | 138.301% |
| HealthStream, Inc. | 15.21 Million USD | 400.97% |
| Certara, Inc. | -55.35 Million USD | 17.288% |
| GeneDx Holdings Corp. | -175.76 Million USD | 73.95% |
| Ontrak, Inc. | -27.92 Million USD | -63.992% |
| SHL Telemedicine Ltd. | -7.05 Million USD | -548.903% |
| CareCloud, Inc. | -48.67 Million USD | 5.932% |
| EUDA Health Holdings Limited | -10.03 Million USD | -356.066% |
| HeartBeam, Inc. | -14.63 Million USD | -212.771% |
| Mangoceuticals, Inc. | -9.21 Million USD | -397.01% |
| CareMax, Inc. | -683.34 Million USD | 93.3% |
| Healthcare Triangle, Inc. | -12.33 Million USD | -271.072% |
| National Research Corporation | 30.97 Million USD | 247.837% |
| Aclarion, Inc. | -4.91 Million USD | -832.257% |
| OptimizeRx Corporation | -17.56 Million USD | -160.657% |